ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 115 filers reported holding ANACOR PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $6,444,000 | -35.4% | 120,563 | +36.5% | 0.01% | -27.3% |
| Q4 2015 | $9,980,000 | -22.7% | 88,343 | -19.4% | 0.01% | -26.7% |
| Q3 2015 | $12,904,000 | -9.8% | 109,623 | -40.6% | 0.02% | +7.1% |
| Q2 2015 | $14,300,000 | +57.1% | 184,683 | +17.4% | 0.01% | +55.6% |
| Q1 2015 | $9,101,000 | +57.6% | 157,302 | -12.1% | 0.01% | +80.0% |
| Q4 2014 | $5,774,000 | +55.5% | 179,035 | +18.0% | 0.01% | +66.7% |
| Q3 2014 | $3,712,000 | +107.1% | 151,685 | +50.0% | 0.00% | +200.0% |
| Q2 2014 | $1,792,000 | -6.7% | 101,101 | +5.3% | 0.00% | -50.0% |
| Q1 2014 | $1,921,000 | +26.6% | 96,028 | +6.2% | 0.00% | +100.0% |
| Q4 2013 | $1,517,000 | +64.7% | 90,382 | +4.2% | 0.00% | 0.0% |
| Q3 2013 | $921,000 | +377.2% | 86,733 | +151.3% | 0.00% | – |
| Q2 2013 | $193,000 | +32.2% | 34,507 | +52.3% | 0.00% | – |
| Q1 2013 | $146,000 | – | 22,654 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $125,702,000 | 41.75% |
| VHCP Management, LLC | 1,178,474 | $138,718,000 | 35.56% |
| Palo Alto Investors LP | 2,579,154 | $303,592,000 | 14.60% |
| Baker Brothers Advisors | 4,135,412 | $486,779,000 | 4.50% |
| APIS CAPITAL ADVISORS, LLC | 23,000 | $2,708,000 | 3.75% |
| EMORY UNIVERSITY | 11,096 | $1,306,000 | 3.64% |
| Atika Capital Management LLC | 61,000 | $7,180,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 488,912 | $57,550,000 | 2.78% |
| Segantii Capital Management Ltd | 100,000 | $11,134,000 | 2.55% |
| NEXT CENTURY GROWTH INVESTORS LLC | 428,835 | $50,478,000 | 2.10% |